Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice Recently, Koike et al. 1 identified a 25-bp deletion in a coding exon of the Disrupted-In-Schizophrenia (DISC1) gene in the 129S6/SvEv strain, which was also confirmed at the genomic level for all extant 129 mouse inbred substrains. 2 This mutation could interfere with the production of the full-length DISC1 protein. When the 129S6/SvEv-derived DISC1 gene was transferred to C57BL/6J genetic background, the resultant mice displayed a subtle behavioral abnormality in working memory, without any other major deficits in behavior and brain anatomy. 1 Several lines of evidence from animal models with RNA interference to DISC1, as well as studies in patient-derived lymphoblasts, suggest that loss of DISC1 function may be involved in the abnormalities underlying the pathophysiology of major mental conditions. 3 The minor behavioral abnormality resulting from the 25-bp deletion is in contrast to the results of three independent groups who have generated partial lossof-function models by expressing dominant-negative DISC1 constructs and obtained substantial changes in behavior, including deficits in prepulse inhibition, latent inhibition and working memory. 4 Moreover, the absence of obvious anatomical changes in the mutant mice 1 conflicts with cellular models based on the knockdown of DISC1 or expression of dominantnegative DISC1, which disrupts developmental processes critical for normal cortical architecture. 5 Thus, if the 25-bp deletion completely abolishes the fulllength DISC1 protein that is crucial for proper neurodevelopment, why are there such small phenotypic changes in mice with this mutation?
To address this question, our collaborative group examined expression of DISC1 protein in the 129S6/ SvEv strain, and systematically compared expression with that in the C57BL/6J strain by using antibodies against more than 10 independent epitopes that were generated from eight independent groups, including commercially available antibodies (Figure 1a) . Although DISC1 has several isoforms, we focused our analyses of immunoreactivity on the one that corresponded to full-length DISC1. Interestingly, all the antibodies except the one that was a generous gift from Dr Joseph A Gogos 1 showed almost identical immunoreactivity to DISC1 at this molecular weight band, or at least immunoreactivity that was indistinguishable at the detection levels, between these two strains ( Figure 1b and Supplementary Figure 1) . The specificity of these antibodies against DISC1 was tested by western blotting with extracts from monkey COS7 cells expressing full-length C57BL/6J-derived mouse DISC1 or with mock transfection (Supplementary Figure 2 ). The specificity of the mExon3 antibody was also confirmed by preabsorption tests by both western blotting and immunohistochemistry (Supplementary Figure 3 ). D27 is the best-characterized antibody against mouse DISC1 in both western blotting and immunohistochemistry. D27 recognizes two distinct bands at 100-110 kDa, corresponding in size to full-length DISC1. 6 We conducted immunoprecipitation (IP) with mouse brain extracts by using the mExon3 antibody, which was followed by western blotting with the D27 antibody, and found that the molecule corresponding to the lower band detected by D27 was specifically precipitated by mExon3. Consistent with the results of western blotting, we failed to observe any difference in IP between the 129S6/SvEv and the C57BL/6J strains. Thus, whereas we were able to confirm a differential immunoreactivity between 129S6/SvEv and C57BL/6J strains with the Koike et al. antibody, we did not find substantial detectable differences in DISC1 proteins between 129S6/SvEv and C57BL/6J strains by western blotting with most of currently available antibodies against DISC1. DISC1 has multiple isoforms at both mRNA and protein levels. 7, 8 In addition to 13 coding exons for the full-length DISC1, a bioinformatic approach suggested that possible exons exist inside the genomic region of the DISC1 gene, such as those reported in the NCBI database (accession no.: XP_001002896). The antibodies used in this study, although their specificities have been confirmed in each laboratory (also shown in Supplementary Figures 2 and 3) , depict different patterns of DISC1 bands in the western blotting, which may reflect the complexity of the molecular entity of DISC1. Immunoprecipitation with the mExon3 antibody followed by detection of the precipitates with the D27 antibody indicates that these two independent antibodies detect the same DISC1 molecule at 100 kDa, but an additional DISC1 band is detected by D27 at 105 kDa (Figure 1c) . Therefore, this suggests that the antibody generated by Koike et al.
1 might specifically detect a unique isoform of DISC1 at 100 kDa that is lost by the 25-bp deletion. Selective detection of this unique isoform in the immunoprecipitates with immunoglobulin G (IgG) from brain extracts of C57BL/6J, but not from those of 129S6/ SvEv, suggests that this isoform has a specific binding affinity to IgG (Supplementary Figure 4) . To resolve such complexity, including the possibility of more than one isoform of similar size, we propose to utilize two-dimensional gel electrophoresis combined with mass spectrometry for further studies. Of note, Arguello and Gogos also disclosed in their preliminary study that they obtained persistent isoforms of DISC1 in C57BL/6J mice that were transferred with the 25-bp deletion.
9 Similar molecular complexity also occurs in another susceptibility gene for schizophrenia, neuregulin-1. 10 The etiology of major mental disorders comprises a combination of changes in genetic factors together with environmental factors. Subtle disturbance of an isoform(s) of susceptibility gene products may well account for the etiology of these disorders. In this sense, the mice reported by Koike et An article recently published in Molecular Psychiatry 1 reported that the cadherin gene (FAT) was associated with increased occurrence of bipolar affective disorder (BPAD) in four independent cohorts. The present investigation attempted to replicate these findings in a different cohort but found no significant association.
The heritable component of BPAD is unequivocal yet the identity of any risk allele remains to be consistently replicated. One proposed susceptibility locus occurs on chromosome 4q35. [2] [3] [4] Blair et al. undertook positional cloning, association tests and gene expression assays and found support for a role of the FAT gene, that resides within that chromosomal region, in relation to BPAD. Our cases were recruited for a family study regarding the molecular genetics of BPAD in Christchurch, New Zealand. Probands were included in the study based on a confirmed bipolar I (BPI) or bipolar II (BPII) diagnosis, suspected family history of spectrum BPAD and at least one living first-degree family member available for interview. 5 All participants were assessed using the Diagnostic Interview for Genetics Studies (DIGS). 6 The control DNA samples were obtained from a representative local cohort for the purpose of population estimates of polymorphism frequencies. All individuals provided written informed consent. This study was approved by the Canterbury Ethics Committee, Christchurch, New Zealand.
All samples were genotyped for two of the three single nucleotide polymorphisms (SNPs) examined by Blair et al.
1 -rs1298865 and rs2306987. Genomic DNA was extracted from peripheral blood using the method of Ciulla et al. 7 Genotyping was undertaken using an allele-specific multiplex polymerase chain reaction (PCR) carried out in two reactions (A and B) for each DNA sample. Each 10 ml PCR contained 0.5 mM of each primer (Invitrogen, Carlsbad, CA, USA), 200 mM each deoxynucleoside triphosphate (Roche, Basel, Switzerland), 0.2 U of Taq polymerase (Eppendorf HotMaster, Hamburg, Germany), 1 Â PCR buffer (Eppendorf HotMaster) and approximately 100 ng of genomic DNA. Primers for reaction A included two common primers used in both reactions (5 0 -TTCTTCGTTTGAGTTTGTAAGGTG-3 0 and 5 0 -GTTAAGAAAGTTGCGAGGAAGATT-3 0 ) and two allele-specific primers for rs2306987 T and rs1298865 T, respectively (5 0 -TGCTGGGGAAAATAGCCAAACTG TTCTTCT-3 0 and 5 0 -TCGCACGATTCGGACTGGAAG GAGCTCATA-3 0 ). Primers for reaction B included the two common primers and two allele-specific primers for rs2306987 A and rs1298865 C, respectively (5 0 -TGCTGGGGAAAATAGCCAAACTGTTCTTCA-3 0 and 5 0 -TCGCACGATTCGGACTGGAAGGAGCTCATG-3 0 ). Thermal cycling was performed with an initial denaturation of 5 min at 951C, followed by 30 cycles of 30 s at 951C, 30 s at 601C, 40 s at 681C, and a terminal extension of 7 min at 681C. Reaction products were analysed on a 2% agarose (Progen Biosciences, Darra, Queensland, Australia) gel, with expected bands of 180 bp for rs2306987 alleles, 289 bp for rs1298865 alleles and 639 bp for the internal reaction control.
Our family-based sample consisted of 91 families, including 76 probands and 254 relatives for whom we had complete clinical and genetic data. Within the relatives, 109 individuals had been diagnosed with depression, 56 had some form of BPAD and 89 had no history of a mood disorder. All probands had been diagnosed with BPAD, including 57 with BPI and 19 with BPII. The mean age of the probands was 35.6 years (S.D 18.6) and 44% were male. The majority of the cohort was of Caucasian ethnicity. For the analyses, the probands were regarded as cases, while the local cohort of volunteers represented controls.
Consistent with Blair et al., 1 we performed w 2 tests to compare the allele and genotype frequencies for
